DOKTAS DOKUMCULUK

The current price of DOKTA is 34.78 TRY — it has increased by 1.05% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange DOKTAS DOKUMCULUK stocks are traded under the ticker DOKTA.

DOKTA stock is 2.23% volatile and has beta coefficient of 0.57. Check out the list of the most volatile stocks — is DOKTAS DOKUMCULUK there?

Yes, you can track DOKTAS DOKUMCULUK financials in yearly and quarterly reports right on TradingView.

DOKTA stock has fallen by 3.39% compared to the previous week, the month change is a 1.81% rise, over the last year DOKTAS DOKUMCULUK has showed a 51.67% increase.

DOKTA net income for the last quarter is ‪385.38 M‬ TRY, while the quarter before that showed ‪−97.10 M‬ TRY of net income which accounts for 496.89% change. Track more DOKTAS DOKUMCULUK financial stats to get the full picture.

No, DOKTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, DOKTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DOKTAS DOKUMCULUK stock right from TradingView charts — choose your broker and connect to your account.

DOKTA reached its all-time high on Oct 6, 2023 with the price of 48.40 TRY, and its all-time low was 0.00274858 TRY and was reached on May 3, 1994.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪3.13 K‬ employees. See our rating of the largest employees — is DOKTAS DOKUMCULUK on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DOKTAS DOKUMCULUK technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DOKTAS DOKUMCULUK stock shows the buy signal. See more of DOKTAS DOKUMCULUK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DOKTAS DOKUMCULUK EBITDA is ‪1.37 B‬ TRY, and current EBITDA margin is 14.32%. See more stats in DOKTAS DOKUMCULUK financial statements.